Recently, the Class 1 innovative drug Prusogliptin Tablets (trade name: 善泽平) of CSPC OUYI PHARMACEUTICAL CO., LTD. is approved for marketing by China NMPA. This product is indicated for improving the blood glucose control of adult patients with type 2 diabetes, providing new treatment options for patients.